Pfizer says COVID-19 pill almost 90% effective preventing severe illness, death

Nov. 5 (UPI) -- Pharma company Pfizer announced on Friday that its experimental, antiviral COVID-19 treatment pill Paxlovid showed during testing that it's almost 90% effective in preventing hospitalization and death in high-risk patients.

The company said when combined with a low dose of ritonavir and taken within five days of the onset of symptoms, it cut severe illness and death attributed to the coronavirus by 89%.

"Today's news is a real game-changer in the global efforts to halt the devastation of this pandemic," Pfizer CEO Albert Bourla said in a statement.
...
More: https://www.upi.com/Top_News/US/2021...9781636113852/